A phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome

This article is protected by copyright. All rights reserved.

Source: Cancer Science - September 1, 2017 Category: Cancer & Oncology Authors: Yasunori Ueda, Michinori Ogura, Shigesaburo Miyakoshi, Takahiro Suzuki, Yuji  Heike, Shuzo Tagashira, Satoru Tsuchiya, Kazuma Ohyashiki, Yasushi  Miyazaki Tags: Original Article Source Type: research